Form 4: Exelixis EVP Haley Vests Significant Stock Award
Insider Transaction Report
Exelixis EVP Patrick J. Haley vested 139,508 shares from a performance-based restricted stock unit award after the Compensation Committee certified performance criteria achievement.
Summary
- Patrick J. Haley, EVP, Commercial of Exelixis, Inc., reported transactions related to performance-based restricted stock units (PSUs).
- On January 15, 2026, the Compensation Committee certified that certain performance criteria had been achieved for a PSU award granted on April 3, 2023.
- This certification resulted in eligibility for vesting up to 175% of the original 79,719 target shares.
- Immediately following the certification on January 15, 2026, 50% of the achieved shares, totaling 139,508 shares of common stock, vested.
- The remaining 50% of the achieved shares are scheduled to vest on February 15, 2027, contingent on continuous service.
- Exelixis, Inc. withheld 32,332 shares at a price of $45.23 to satisfy tax obligations related to the vesting.
- Following these transactions, Patrick J. Haley beneficially owns 481,205 shares of Exelixis, Inc. common stock directly.
- This beneficial ownership includes 443,784 shares from other restricted stock units (RSUs) and One-Time Award PSUs granted on March 31, 2025, which will be issued upon their respective vesting.
Sentiment
Score: 8
Explanation: The sentiment is positive as the vesting of performance-based stock units indicates the company successfully met its performance criteria, leading to a higher payout for the executive. This reflects positively on the company's operational and financial execution.
Positives
- The Compensation Committee certified the achievement of certain performance criteria, indicating strong company performance.
- The achievement of performance criteria resulted in eligibility for vesting up to 175% of the target shares, demonstrating successful execution against set goals.
Negatives
- 32,332 shares were disposed of to cover tax liabilities associated with the vesting of the PSUs.
Future Outlook
The remaining 50% of the performance-based restricted stock units (PSUs) are scheduled to vest on February 15, 2027, provided the reporting person maintains continuous service with the company.
Industry Context
Performance-based equity awards, such as the PSUs described, are a common compensation mechanism in the biotechnology and pharmaceutical industries. They are designed to align executive incentives with long-term company performance and shareholder value creation, encouraging executives to meet specific operational and financial milestones.
Stakeholder Impact
- Shareholders: The achievement of performance criteria for executive compensation suggests strong company performance, which could be viewed positively.
- Employees: The successful vesting of executive equity awards can signal a healthy company environment and potentially motivate other employees.
Next Steps
- The remaining 50% of the achieved performance-based restricted stock units are scheduled to vest on February 15, 2027, subject to the reporting person's continuous service.
Key Dates
| Date | Description |
|---|---|
| 04/03/2023 | Date of grant for the performance-based restricted stock unit (PSU) award covering 79,719 target shares. |
| 03/31/2025 | Date of grant for other restricted stock units (RSUs) and One-Time Award PSUs. |
| 01/15/2026 | Date the Compensation Committee certified achievement of performance criteria for the PSU award, resulting in immediate vesting of 50% of achieved shares and disposition of shares for taxes. |
| 01/16/2026 | Date the Form 4 was signed by Nina Ayer, Attorney in Fact. |
| 02/15/2027 | Scheduled vesting date for the remaining 50% of the achieved PSU shares, subject to continuous service. |
Keywords
Exelixis, EXEL, Form 4, Insider Transaction, Executive Compensation, Performance Stock Units, PSU Vesting, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.